RepliCel Life Operating Margin vs. Market Capitalization

RP Stock  CAD 0.01  0.01  33.33%   
Based on the measurements of profitability obtained from RepliCel Life's financial statements, RepliCel Life Sciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess RepliCel Life's ability to earn profits and add value for shareholders.

RepliCel Life Operating Profit Margin

(4.11)

At this time, RepliCel Life's EV To Sales is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 5.46 in 2024, whereas Price To Sales Ratio is likely to drop 10.34 in 2024. At this time, RepliCel Life's Total Other Income Expense Net is fairly stable compared to the past year. Change To Netincome is likely to climb to about 2.3 M in 2024, whereas Operating Income is likely to drop (1.5 M) in 2024.
For RepliCel Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of RepliCel Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well RepliCel Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between RepliCel Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of RepliCel Life Sciences over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between RepliCel Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if RepliCel Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RepliCel Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

RepliCel Life Sciences Market Capitalization vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining RepliCel Life's current stock value. Our valuation model uses many indicators to compare RepliCel Life value to that of its competitors to determine the firm's financial worth.
RepliCel Life Sciences is currently regarded as top stock in operating margin category among its peers. It also is currently regarded as top stock in market capitalization category among its peers . At this time, RepliCel Life's Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RepliCel Life's earnings, one of the primary drivers of an investment's value.

RepliCel Market Capitalization vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

RepliCel Life

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(0.74) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

RepliCel Life

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
1.1 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

RepliCel Market Capitalization vs Competition

RepliCel Life Sciences is currently regarded as top stock in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 920.26 Million. RepliCel Life adds roughly 1.1 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Total debt  Valuation  Revenue  Workforce

RepliCel Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in RepliCel Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, RepliCel Life will eventually generate negative long term returns. The profitability progress is the general direction of RepliCel Life's change in net profit over the period of time. It can combine multiple indicators of RepliCel Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income624.6 K555.2 K
Operating Income-1.4 M-1.5 M
Income Before Tax-311.7 K-327.3 K
Total Other Income Expense Net1.1 M1.1 M
Net Loss-311.7 K-327.3 K
Income Tax Expense(1.00)(1.05)
Net Loss-69.3 K-72.8 K
Net Loss-4.7 M-4.9 M
Net Interest Income-1.1 K-1.1 K
Interest Income 725.00  688.75 
Change To Netincome2.2 M2.3 M
Net Loss(0.01)(0.01)
Income Quality 4.54  4.76 
Net Loss(0.09)(0.08)

RepliCel Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on RepliCel Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of RepliCel Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the RepliCel Life's important profitability drivers and their relationship over time.

Use RepliCel Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RepliCel Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RepliCel Life will appreciate offsetting losses from the drop in the long position's value.

RepliCel Life Pair Trading

RepliCel Life Sciences Pair Trading Analysis

The ability to find closely correlated positions to RepliCel Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RepliCel Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RepliCel Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RepliCel Life Sciences to buy it.
The correlation of RepliCel Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RepliCel Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RepliCel Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RepliCel Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your RepliCel Life position

In addition to having RepliCel Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Defence Thematic Idea Now

Aggressive Defence
Aggressive Defence Theme
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.